Cargando…

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

BACKGROUND: The first meningococcal serogroup C (MenC) conjugate vaccine was licensed in 1999 and introduced in the United Kingdom. Countries that have implemented the MenC vaccine since then in their national immunisation programmes use different schedules. Nevertheless, all involved countries seem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaaijk, Patricia, van der Ende, Arie, Berbers, Guy, van den Dobbelsteen, Germie PJM, Rots, Nynke Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293716/ https://www.ncbi.nlm.nih.gov/pubmed/22316426 http://dx.doi.org/10.1186/1471-2334-12-35

Ejemplares similares

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Meningococcal Serogroup A, C, W(135) and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands
por: Hepkema, Hiltsje, et al.
Publicado: (2013)

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine
por: van Ravenhorst, Mariëtte B., et al.
Publicado: (2018)

CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity
por: Vermont, Clementien L, et al.
Publicado: (2006)

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
por: Knol, Mirjam J, et al.
Publicado: (2018)

Carriage of Streptococcus pneumoniae 3 Years after Start of Vaccination Program, the Netherlands
por: Spijkerman, Judith, et al.
Publicado: (2011)

Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine
por: de Voer, Richarda M., et al.
Publicado: (2010)

Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers
por: Stoof, Susanne P., et al.
Publicado: (2014)

Sequence Diversity within the Capsular Genes of Streptococcus pneumoniae Serogroup 6 and 19
por: Elberse, Karin, et al.
Publicado: (2011)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
por: Gamougam, Kadidja, et al.
Publicado: (2015)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012)

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017
por: Krone, Manuel, et al.
Publicado: (2019)

Protection against invasive meningococcal disease and vaccination policy in the Netherlands
por: Ohm, M, et al.
Publicado: (2022)

Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands
por: Vissers, Marloes, et al.
Publicado: (2018)

Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004–2016
por: Brandwagt, Diederik A. H., et al.
Publicado: (2019)

Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017
por: Fernandez, Katya, et al.
Publicado: (2019)

One statistical test is sufficient for assessing new predictive markers
por: Vickers, Andrew J, et al.
Publicado: (2011)

Salivary Immune Responses to the 7-Valent Pneumococcal Conjugate Vaccine in the First 2 Years of Life
por: Rodenburg, Gerwin D., et al.
Publicado: (2012)

Serogroup Y Meningococcal Disease, Colombia
por: Agudelo, Clara Inés, et al.
Publicado: (2008)

Different Long-Term Duration of Seroprotection against Neisseria meningitidis in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination in The Netherlands
por: Ohm, Milou, et al.
Publicado: (2020)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
por: Hedari, Carine P, et al.
Publicado: (2014)

Age-Related Immunity to Meningococcal Serogroup C Vaccination: An Increase in the Persistence of IgG2 Correlates with a Decrease in the Avidity of IgG
por: de Voer, Richarda M., et al.
Publicado: (2011)

Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?
por: Stoof, Susanne P., et al.
Publicado: (2015)

Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018
por: Bwaka, Ado, et al.
Publicado: (2019)

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
por: Racloz, Vanessa N, et al.
Publicado: (2010)

Serogroup X in Meningococcal Disease, Western Kenya
por: Materu, Sadiki, et al.
Publicado: (2007)

Toward an Improved Meningococcal Serogroup B Assay
por: Poolman, Jan
Publicado: (2018)

Autonomy of the child in the South African context: is a 12 year old of sufficient maturity to consent to medical treatment?
por: Ganya, Wandile, et al.
Publicado: (2016)

Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1
por: van Westen, Els, et al.
Publicado: (2018)

Vaccination against RSV: Is maternal vaccination a good alternative to other approaches?
por: Kaaijk, Patricia, et al.
Publicado: (2013)

Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine
por: Topaz, Nadav, et al.
Publicado: (2020)

A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine
por: Perrett, Kirsten P., et al.
Publicado: (2013)

Constructing maternal morbidity – towards a standard tool to measure and monitor maternal health beyond mortality
por: Chou, Doris, et al.
Publicado: (2016)

Serogroup W135 Meningococcal Disease, The Gambia, 2012
por: Hossain, M. Jahangir, et al.
Publicado: (2013)

An Unexpected Fever Post Serogroup B Meningococcal Sepsis
por: Donà, Daniele, et al.
Publicado: (2016)

Meningococcal serogroups and surveillance: a systematic review and survey
por: Peterson, Meagan E, et al.
Publicado: (2019)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5ksaej97f6evbbuvm8d8ghl551